Osanni Bio is a development-stage therapeutics platform, headquartered in San Francisco, California. At the center of Osanni is its innovation engine, which is optimized for discovering new scientific insights, designing novel drug concepts, and efficiently advancing programs to a meaningful proof-of-concept. Once a program is sufficiently de-risked, it graduates into its ecosystem of affiliate companies, which are equipped with the dedicated focus, specialized talent and support necessary to scale. Osanni's architecture marries the scientific depth and operational power of a centralized platform with the speed, agility and accountability of independent companies.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
07/01/26	$190,000,000	Series B	Horowitz Group INVUS Opportunities Patient Square Capital Retinal Degeneration Fund	undisclosed